- Home
- SYRE vs PLYM Comparison
SYRE vs PLYM Comparison
Compare SYRE & PLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- PLYM
- Stock Information
- Founded
- SYRE 2013
- PLYM 2011
- Country
- SYRE United States
- PLYM United States
- Employees
- SYRE N/A
- PLYM N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- PLYM Real Estate Investment Trusts
- Sector
- SYRE Health Care
- PLYM Real Estate
- Exchange
- SYRE Nasdaq
- PLYM Nasdaq
- Market Cap
- SYRE 1.1B
- PLYM 981.1M
- IPO Year
- SYRE 2016
- PLYM 2017
- Fundamental
- Price
- SYRE $23.56
- PLYM $22.02
- Analyst Decision
- SYRE Strong Buy
- PLYM Hold
- Analyst Count
- SYRE 6
- PLYM 7
- Target Price
- SYRE $57.60
- PLYM $21.67
- AVG Volume (30 Days)
- SYRE 1.3M
- PLYM 722.5K
- Earning Date
- SYRE 11-06-2025
- PLYM 10-31-2025
- Dividend Yield
- SYRE N/A
- PLYM 4.35%
- EPS Growth
- SYRE N/A
- PLYM 439.08
- EPS
- SYRE N/A
- PLYM 2.89
- Revenue
- SYRE N/A
- PLYM $171,801,000.00
- Revenue This Year
- SYRE N/A
- PLYM $1.88
- Revenue Next Year
- SYRE N/A
- PLYM $9.24
- P/E Ratio
- SYRE N/A
- PLYM $7.64
- Revenue Growth
- SYRE N/A
- PLYM N/A
- 52 Week Low
- SYRE $10.91
- PLYM $12.70
- 52 Week High
- SYRE $40.26
- PLYM $22.65
- Technical
- Relative Strength Index (RSI)
- SYRE 70.08
- PLYM 60.36
- Support Level
- SYRE $21.88
- PLYM $21.95
- Resistance Level
- SYRE $24.02
- PLYM $22.24
- Average True Range (ATR)
- SYRE 1.62
- PLYM 0.33
- MACD
- SYRE 0.32
- PLYM -0.07
- Stochastic Oscillator
- SYRE 93.11
- PLYM 89.19
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.